Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Experts put FREEDOM findings in perspective
• FDA: Pradaxa not linked to excess bleeding risk
• New statement outlines recommendations for use of mechanical circulatory support
• NIH study halted: Weight loss failed to improve CVD outcomes
• Reusing explanted ICDs may be safe, effective
• Risk of ischemic, hemorrhagic stroke higher in elderly THA patients
• Smoke-free laws linked to declines in hospitalization, MI
• FDA approves Xarelto for treatment of DVT, PE
• Experts discuss HT use 10 years after the Women's Health Initiative
• New treatment options for familial hypercholesterolemia on the horizon
• CHD, stroke risk heightened with early menopause
• Cognitive training after CABG found beneficial in elderly population
• Drug-eluting balloons reduced restenosis vs. conventional balloons
• FAME substudy: FFR-guided PCI benefits women, men equally
• FDA advisories on ICDs not linked to increased mortality
• Four risk factors strongly predictive of PAD in men
• Higher mortality rates found in smokers with CAC
• Hypertension in pregnancy may affect child’s cognition in old age
• Incidence of AF increased in older patients initiating dialysis
• MRI technique may identify early indicator of atherosclerosis
• NHANES: Cholesterol levels improve among US adults
• PET, CMR appeared comparable, accurate for detection of acute CAD
• Prediction tool identified disability, death risk after stroke
• Racial/ethnic gaps in CRT-D use narrowing, but disparities still exist
• Researchers identify evidence-based public health interventions for policy makers
• Review finds no benefit from routine general health checks
• Study associates eating chocolate with winning Nobel prizes
• Sulfonylureas increased risk for CVD events, death
• Survey results reveal changing practice patterns in nuclear cardiology
• Urgent need for investigation of inotropic agents in HF patients
• ADAPT-DES: Low responsiveness to clopidogrel after DES predicted stent thrombosis, MI
• AHA Conference Blog: Tempered enthusiasm for novel approaches to address cholesterol
• Cost analysis shows mixed results for drug-eluting balloons
• CPORT-E: PCI costs higher in hospitals without onsite cardiac surgery unit
• Dalcetrapib increased HDL, did not reduce risk for CV events
• DEFINITIVE LE: Directional atherectomy effective for PAD
• FAME II: FFR-guided PCI cost effective vs. medical therapy
• GAUSS: PCSK9 antibody reduced LDL in statin-intolerant patients
• MADIT-RIT: ICD programming change reduced inappropriate therapy
• No benefit noted with postconditioning after primary PCI
• PARADOX: Smoking influences pharmacokinetics and pharmacodynamics of clopidogrel
• RELAX-AHF: Serelaxin improved symptoms, CV mortality in hospitalized HF patients
• RESPECT, PC trials examine outcomes with PFO closure device
• SCIPIO: Cardiac stem cells may be effective HF treatment
• STANCE: OCT assessment confirms safety of bioresorbable scaffold in SFA lesions
• Statin use may protect against esophageal cancer
• STEMI-RADIAL: Radial approach enhanced outcomes in PCI
• TACT: Chelation therapy reduced adverse events in post-MI patients
• UMPIRE: Polypill strategy improved adherence, systolic BP, LDL
• Determining optimal duration of DAPT after coronary artery stenting Douglas L. Jennings, PharmD, BCPS (AQ-CV); Meredith Grycki, PharmD
• FDA Approves Expanded Indication for Sapien Valve
• BLOCK-HF
• DEBATE-SFA
• ETAP
• LAPLACE-TIMI 57
• POSEIDON
• RIME
• SWISS AMI
• XIMA